Following these proceedings, National Securities initiated its Genprex Inc [GNPX] rating to a Buy in a research note published on January 26, 2021; the price target was $7. A number of analysts have revised their coverage, including Noble Capital Markets’s analysts, who began to cover the stock in late April with a ‘”an Outperform”‘ rating.
Price Performance Review of GNPX
On Monday, Genprex Inc [NASDAQ:GNPX] saw its stock fall -6.21% to $0.23. Over the last five days, the stock has lost -15.53%. Genprex Inc shares have fallen nearly -73.57% since the year began. Nevertheless, the stocks have fallen -89.81% over the past one year. While a 52-week high of $4.09 was reached on 01/02/25, a 52-week low of $0.22 was recorded on 04/21/25. SMA at 50 days reached $0.3508, while 200 days put it at $0.8921.
Levels Of Support And Resistance For GNPX Stock
The 24-hour chart illustrates a support level at 0.2151, which if violated will result in even more drops to 0.2050. On the upside, there is a resistance level at 0.2401. A further resistance level may holdings at 0.2550. The Relative Strength Index (RSI) on the 14-day chart is 37.25, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0386, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 97.65%. Stochastics %K at 6.94% indicates the stock is a buying.
How much short interest is there in Genprex Inc?
A steep rise in short interest was recorded in Genprex Inc stocks on 2025-03-31, dropping by -0.36 million shares to a total of 0.28 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-28 was 0.63 million shares. There was a decline of -128.27%, which implies that there is a negative sentiment for the stock.
